Open AccessErratum for Wire et al., Lack of Clinically Significant Pharmacokinetic Interaction between the Thrombopoietin Receptor Agonist Eltrombopag and Hepatitis C Virus Protease Inhibitors Boceprevir and Telaprevir
Author(s) -
Mary Beth Wire,
Fang Lei,
Azra Hussaini,
Joseph F. Kleha,
Dickens Theodore
Publication year - 2015
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00567-15
Subject(s) - boceprevir , eltrombopag , telaprevir , thrombopoietin receptor , virology , medicine , agonist , thrombopoietin , hepatitis c virus , pharmacokinetics , pharmacology , virus , receptor , biology , immunology , haematopoiesis , antibody , genetics , ribavirin , immune thrombocytopenia , stem cell
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom